Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
CA: a Cancer Journal for Clinicians
|
April 15, 2003
Clinical research by community oncologists
Gary I Cohen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group
Michael B Atkins, Jessie Hsu, Sandra Lee, et al.
Cancer
|
June 18, 2011
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort
Tomasz P Srokowski, James E Liebmann, Manuel R Modiano, et al.
Journal of Cancer Survivorship : Research and Practice
|
May 21, 2021
The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote
Jennifer Y Sheng, Cesar A Santa-Maria, Amanda L Blackford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2017
Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)
Lisa H Butterfield, Fengmin Zhao, Sandra Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2015
Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697)
David H Lawson, Sandra Lee, Fengmin Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2002
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
Andrew L Pecora, Naiyer Rizvi, Gary I Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2008
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants
Martee L Hensley, Karen L Hagerty, Tarun Kewalramani, et al.
Cancer
|
March 24, 2017
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607)
Kevin Kalinsky, Sandra Lee, Krista M Rubin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
August 27, 2022
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609
Laurie E McLouth, Yue Zheng, Stephanie Smith, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
CA: a Cancer Journal for Clinicians
|
April 15, 2003
Clinical research by community oncologists
Gary I Cohen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group
Michael B Atkins, Jessie Hsu, Sandra Lee, et al.
Cancer
|
June 18, 2011
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort
Tomasz P Srokowski, James E Liebmann, Manuel R Modiano, et al.
Journal of Cancer Survivorship : Research and Practice
|
May 21, 2021
The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote
Jennifer Y Sheng, Cesar A Santa-Maria, Amanda L Blackford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2017
Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)
Lisa H Butterfield, Fengmin Zhao, Sandra Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2015
Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697)
David H Lawson, Sandra Lee, Fengmin Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2002
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
Andrew L Pecora, Naiyer Rizvi, Gary I Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2008
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants
Martee L Hensley, Karen L Hagerty, Tarun Kewalramani, et al.
Cancer
|
March 24, 2017
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607)
Kevin Kalinsky, Sandra Lee, Krista M Rubin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
August 27, 2022
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609
Laurie E McLouth, Yue Zheng, Stephanie Smith, et al.
Page
of 2